BI 1218.22 CARMELINA

Investigator: Mahendra Jain, MD

Study Coordinator: Bela Jain

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT01897532

Phone: 281.485.3434

IRB Number: Pro00013383

Description

The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with T2DM and to compare outcomes against placebo, on a background of standard of care.
More to Explore